In a BSE filing, Sun Pharmaceutical Industries said: One of the company's wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs). It further said: These old Money Today, 1 month ago
BRIEF-Sun Pharmaceutical Industries announces voluntary withdrawal of 28 ANDAs - Reuters UK, 1 month ago
Sun Pharma slips as its arm voluntarily withdraws 28 ANDAs in US - Finalaya.com, 4 weeks ago
Drugmaker Sun Pharmaceutical Industries has voluntarily requested the United States Food and Drug Administration to withdraw approvals given to 28 Abbreviated New Drug Applications (ANDAs). These older drug products belong to erstwhile Ranbaxy Laboratories ...Business Line, 1 month ago
, the courts upheld a favorable verdict for AstraZeneca and Ranbaxy, ruling that the companies did not violate antitrust laws several years ago with an alleged pay for delay deal. But these two drug makers aren't the only winners. The ruling is a ...Uranium Investing News, 1 month ago AstraZeneca, Ranbaxy prevail in landmark pay-for-delay case FiercePharma, 1 month ago ASTRAZENECA : U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust trial 4 Traders, 1 month ago U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust ... Investing.com, 1 month ago
Finasteride Market: Industry Analysis Report, Regional Outlook, Application Development Potential & Forecast, 2016 2024.
"Finasteride market share comprises of Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Dr. Reddys Laboratories and Intas Pharmaceuticals, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, ...Digital Journal, 1 month ago
NEW DELHI: Malvinder and Shivinder Singh, former promoters of Ranbaxy Laboratories, have a week to respond to the Delhi High Court on an application filed by Daiichi Sankyo, which is seeking to block the brothers from selling their assets. As ET ...Economic Times, 1 day ago Daiichi moves Delhi HC for restraining dilution of assets by Singh brothers Livemint.com, 2 days ago
India Infoline News Service | Mumbai | January 17, 2017 09:55 IST Check out the companies which will be in focus during trade today based on recent and latest news developments. Article saved successfully to my page. You must be Logged in to ...India Infoline, 2 days ago Sun Pharma: Down but not out Smart Investor, 3 weeks ago SUN PHARMACEUTICAL INDUSTRIES : Pharma completes acquisition of 85.1% of Jio Biosintez, stocks down marginally 4 Traders, 4 weeks ago Sun Pharma Q2 profit more than doubles, beats estimates Sify, 2 months ago
More from: , PharmaCompass...and 1 other sources
View: 430 The New Year began with the JP Morgan Healthcare Conference— the drug industry's annual investor meet — where industry leaders were busy announcing deals, until Donald Trump accused the industry of getting away with murder. His ...PharmaCompass, 1 week ago
Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros (SPARC), BromSite/DexaSite (Insite), Absorica (Ranbaxy), and Dusa drug products. Sun announced that its ...Financial Express, 1 week ago
MUMBAI: Taro Pharmaceutical, the American unit of India's Sun Pharmaceutical Industries, is being sued by its investors for what they allege making false and misleading statements on fixing the price of generic drugs in violation of US antitrust ...Economic Times, 4 weeks ago SUN PHARMACEUTICAL INDUSTRIES : Pharma strong and healthy 4 Traders, 1 month ago ET 500: Sun Pharma strong and healthy Economic Times, 1 month ago India Pharma Week 2016 debuts at CpHI & P-MEC India with Pre-Connect Congress Express Pharma, 2 months ago
More from: , Livemint.com...and 2 other sources
MUMBAI (NewsRise) -- Sun Pharmaceutical Industries has named company veteran and Chief Financial Officer Uday Baldota as the new chief executive of its U.S. unit, as India's largest drug maker braces for challenging times in its biggest market amid ...Nikkei Asian Review, 1 month ago Taro appoints Sun Pharma CFO Uday Baldota its CEO Moneycontrol.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!